Corrigendum to “Protosappanin A protects against experimental autoimmune myocarditis, and induces metabolically reprogrammed tolerogenic DCs” (Pharmacol. Res. 146 (2019) 104269)
Titel:
Corrigendum to “Protosappanin A protects against experimental autoimmune myocarditis, and induces metabolically reprogrammed tolerogenic DCs” (Pharmacol. Res. 146 (2019) 104269)